)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
XP Chemistries
XP Chemistries (XPC) investor relations material
XP Chemistries Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2026 earnings summary25 Aug, 2026
Executive summary
Commercialization phase advanced from planning to execution, with pilot-scale production at two contract manufacturers and progress toward full product launch with a European distributor.
Achieved a key milestone in scaling up capsaicin production, confirming technical feasibility and comparable or superior product quality to EU-approved material.
Secured first patent in the third patent family in Japan, strengthening IP position.
Board strengthened with new members experienced in capital markets and industrial business development.
Financial highlights
Net sales for Jan–Jun 2026: 192 TSEK (199 TSEK year-over-year); Q2 net sales: 59 TSEK (96 TSEK year-over-year).
Operating loss for Jan–Jun 2026: -5,980 TSEK (-4,642 TSEK year-over-year); Q2 operating loss: -2,912 TSEK (-2,519 TSEK year-over-year).
Result before tax for Jan–Jun 2026: -5,978 TSEK (-4,674 TSEK year-over-year); Q2: -2,911 TSEK (-2,530 TSEK year-over-year).
Earnings per share for Jan–Jun 2026: -0.02 SEK (-0.02 SEK year-over-year); Q2: -0.01 SEK (-0.01 SEK year-over-year).
Cash and cash equivalents at June 30, 2026: 9,709 TSEK (218 TSEK year-over-year).
Outlook and guidance
Certification process (FAMI-QS) in final stage, expected completion in Q3 2026, enabling first encapsulated product market launch around year-end.
Market demand for capsaicin-based feed additives is increasing, driven by heat stress in livestock and reduced antibiotic use.
Two product candidates selected for further evaluation and production tests underway with feed producers.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from XP Chemistries
- Q1 2026 saw higher sales, deeper commercialization, and a strengthened IP position.XPC
Q1 2026 - EU approval and a new distribution deal mark a commercial breakthrough for encapsulated capsaicin.XPCQ4 2025
- EU approval enables commercial launch of high-purity capsaicin feed additives; losses widen.XPCQ3 2025
- EU approval paves way for commercial launch; rights issue boosts capital for growth.XPCQ2 2025
- Q3 2024 saw lower sales, improved losses, and a regulatory delay for XP Chemistries.XPCQ3 2024
- XP Chemistries advanced EFSA approval and improved margins, preparing for a 2025 launch.XPCQ2 2024
- Narrowed losses and regulatory progress position XP Chemistries for a 2025 commercial launch.XPCQ4 2024
- EFSA approval for capsaicin positions XP Chemistries for EU market launch in 2025.XPCQ1 2025
Next XP Chemistries earnings date
Q3 202619 Nov, 2026
XP Chemistries
Next XP Chemistries earnings date
Q3 202619 Nov, 2026
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
XP Chemistries AB is a biotechnology company that specializes in developing and patenting innovative, nature-inspired chemical processes. The company focuses on producing high-quality and sustainable natural chemicals using environmentally friendly technologies. Its key products include biobased capsaicin and nonivamide, which are derived from sustainable raw materials like wood and lignin from the pulp and paper industry. These products serve various sectors including animal feed, cosmetics, and personal care, as well as ingredients for self-defense sprays. The company is headquartered in Sundsvall, Sweden, and its shares are listed on the Stockholm Stock Exchange.